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Tyrothricin, a complex mixture of antibiotic peptides from Bacillus brevis, was reported in 1944 to have antimalarial activity rivalling that of
quinine in chickens infected with Plasmodium gallinaceum. We have isolated the major components of tyrothricin, cyclic decapeptides
collectively known as the tyrocidines, and tested them against the human malaria parasite Plasmodium falciparum using standard in vitro assays.
Although the tyrocidines differ from each other by conservative amino acid substitutions in only three positions, their observed 50% parasite
inhibitory concentrations (IC50) spanned three orders of magnitude (0.58 to 360 nM). Activity correlated strictly with increased apparent
hydrophobicity and reduced total side-chain surface area and the presence of ornithine and phenylalanine in key positions. In contrast, mammalian
cell toxicity and haemolytic activities of the respective peptides were considerably less variable (2.6 to 28 μM). Gramicidin S, a structurally
analogous antimicrobial peptide, was less active (IC50=1.3 μM) and selective than the tyrocidines. It exerted its parasite inhibition by rapid and
selective lysis of infected erythrocytes as judged by fluorescence and light microscopy. The tyrocidines, however, did not cause an overt lysis of
infected erythrocytes, but an inhibition of parasite development and life-cycle progression.
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Malaria is endemic in 107 third world countries, with an
estimated 402 million clinical malaria cases in 2004 [http://
www.rbm.who.int/wmr2005/; 1]. This level of incidence
correlates with 0.7 to 3 million deaths annually [1], of which
more than 70% are children under the age of 5 years. Of
particular concern is the estimated 270–400 million malaria
cases [1] caused by Plasmodium falciparum, of which a large
number of strains are drug resistant, in particular towards
chloroquine [2]. The global resistance of malaria parasites
towards chloroquine is probably the consequence of its
extensive use as antimalarial drug [2,3]. Reports of field strains
of P. falciparum demonstrating in vitro resistance to the⁎ Corresponding author. Tel.: +27 21 406 6498; fax: +27 21 448 1989.
E-mail address: hhoppe@uctgsh1.uct.ac.za (H.C. Hoppe).
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doi:10.1016/j.bbamem.2007.01.015artemisinins, recently introduced as antimalarial drugs, are
also disconcerting [4,5]. There is consequently an urgent need
for new effective antimalarial agents.
Since the discovery of penicillin, a variety of secondary
metabolites from fungi and bacteria (i.e. staphylococcus,
streptomyces and bacilli species) have been identified and
applied as antibiotics and chemotherapeutic agents [6]. An
extremely active search was initiated after the Second World
War for new antibiotics against a variety of pathogens,
including Plasmodium species [7]. During this period many
compounds, such as gramicidin D and tyrothricin from Bacillus
brevis strains, were found to be active against malaria parasites
[8]. The activity of tyrothricin was observed to rival that of
quinine when tested in chickens infected with Plasmodium
gallinaceum. However, neither tyrothricin nor gramicidin D
reached the status of an antimalarial drug. The potent anti-
malarial activity of gramicidin D has been revisited recently
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not been further investigated and thus warrants closer inspec-
tion, albeit more than 60 years later.
Tyrothricin is a complex mixture of B. brevis peptides and
can contain the nine ribosomally produced linear gramicidins
(gramicidin D) as well as up to 28 different non-ribosomally
produced tyrocidines and tryptocidines [11]. The previously
reported tyrothricin antimalarial activity [8] could be attribu-
table to gramicidin D. However, the larger fraction of tyrothricin
is composed of the tyrocidines [11] and it is therefore likely that
these peptides also possess antiplasmodial activity. Further-
more, gramicidin S, a Brevibacillus brevis cyclic peptide
antibiotic closely related to tyrocidines, has been shown to be
antiplasmodial [9,12]. The tyrocidines also share with grami-
cidin S the features of broad-spectrum antibacterial and potent
haemolytic activities [13–16].
It is accepted that the activity of most antimicrobial peptides
is due to their membranolytic properties [17–19] and both
tyrocidine A and gramicidin S have been shown to disrupt
membrane permeability [20,21]. The membrane active B. brevis
peptides may be an attractive group of antimalarial compounds,
since their lytic mechanism of action conceivably makes it
difficult for pathogens to develop resistance. This prompted us
to isolate and investigate the parasite-inhibitory properties of the
major individual tyrocidines in the tyrothricin complex and
gramicidin S using standard dose–response assays and light
microscopy.
2. Materials and methods
2.1. Peptides
Gramicidin S from Brevibacillus brevis (Nagano) and tyrothricin from
Bacillus brevis were purchased from Sigma-Aldrich (Steinheim, Germany).
The tyrocidines were purified from tyrothricin by reverse phase HPLC and
analysed for purity by electrospray mass spectrometry (ESMS) and ultra
performance liquid chromatography linked to mass spectrometry (UPLC-MS),
as described below.
Insoluble particulates in purified peptide preparations were removed
beforehand by centrifugation (10 min at 8600×g). In order to ensure sterility,
all the peptides were dissolved in 50% acetonitrile and freeze-dried in pyrolysed
glassware (washed dry glasswarewas heated to 560 °C for 1 h). The peptideswere
weighed using an analytical protocol (drying of peptides under vacuum before
duplicate/triplicate weighing on a 6-digit analytical scale). The scale chamber
was kept free of water by placing dry phosphorpentoxide in a beaker inside
the chamber. The analytically weighed peptide fractions were used to prepare
1.00–3.00 mg/mL stock solutions in 50% ethanol shortly before each assay. The
concentration of each stock solution was confirmed by amino acid analysis.
Dilutions of stock solutions were done with RPMI-1640 culture medium.
2.2. HPLC fractionation of tyrocidines
The crude tyrocidine fraction was prepared by washing 50 mg of the
commercially obtained tyrothricin three times with 5 mL acetone:diethyl ether
(1:1, v/v) [22]. The undissolved peptide material was collected by centrifugation
and dried under vacuum before further HPLC purification. Semi-preparative
HPLC was used to purify tyrocidines A, A1, B, B1, C and C1 from the crude
fraction. Samples (20 mg/mL) were dissolved in 50% HPLC-grade acetonitrile,
centrifuged for 10 min at 8600×g to remove particulates and subjected to
purification on a semi-preparative Novapak HR C18 HPLC column (6 μm
spherical particles, 300 mm×7.8 mm; Millipore-Waters, La Jolla, USA). A
linear gradient over 23 min at a flow rate of 3.0 mL/min was created from 50%eluant A (0.1% trifluoroacetic acid in analytical quality water) to 80% eluant B
(90% acetonitrile and 10% A).
The tyrocidines A and A1 were further purified on an analytical C18 Novapak
HPLC column (4 μm spherical particles, 60 Å pore size, 150 mm×3.9 mm;
Millipore-Waters, La Jolla, USA), using the same gradient with a 1.0 mL/min
flow rate. The chromatography was monitored at 254 nm with a Waters Model
440 UV-detector. Peptide fractions were collected, lyophilised and analysed with
ESMS and UPLC™-MS. The same protocol was also used for analytical runs.
2.3. ESMS and UPLC-MS of peptides
Electrospray ionisation mass spectrometry (ESMS) was performed on a
Waters Q-Tof Ultima mass spectrometer fitted with a Z-spray electrospray
ionisation source. Five or 10 μL of the sample solution (50 or 100 ng peptide in
50% acetonitrile) was introduced into the ESMS via Waters Acquity UPLC™.
The carrier solvent was 50% acetonitrile in 0.1% formic acid, delivered at a flow
rate of 300 μL/min during each analysis. A capillary voltage of 3.5 kV was
applied, with the source temperature set at 100 °C and cone voltage at 35 V. Data
acquisition was in the positive mode, scanning the second analyser (MS2),
through m/z=100–1999 (m/z is defined as the molecular mass to charge ratio).
Representative scans were produced by combining the scans across the elution
peak and subtracting the background.
UPLC-MS analysis was done on a Waters Acquity Ultra Performance Liquid
Chromatograph connected to the above Waters Q-TOF Ultima mass spectro-
meter. Separation was achieved on a Waters UPLC BEH C18 column
(2.1×50 mm, 1.7 μm spherical particles, Millipore-Waters, La Jolla, USA),
using a 0.1% trifluoroacetic acid (A) to acetonitrile (B) gradient (100% A for
30 s, 0 to 30% B from 30 to 60 s, 30 to 60% B from 1 to 10 min, 60 to 80% B
from 10 to 15 min at a flow rate 300 μL/min), followed by re-equilibration of the
column to initial conditions.
2.4. Parasite viability and haemolysis dose–response assays
P. falciparum (3D7 strain) was cultured under an atmosphere of 3% CO2, 4%
O2 and 93% N2 in RPMI-1640 medium supplemented with 50 mM glucose,
0.65 mM hypoxanthine, 25 mM HEPES, 0.2% (w/v) NaHCO3, 0.048 mg/mL
gentamicin, 0.5% (w/v) Albumax II and 2–4% (v/v) human O+ erythrocytes.
Culture-derived parasitised erythrocytes were mixed with fresh culture medium
and erythrocytes to yield a 2% parasitemia and 2% haematocrit suspension and
distributed in microtitre plates at 90 μL/well. A 10 μL aliquot of serial dilutions
of peptide in media was added to the parasite suspension. The plates were
incubated at 37 °C for 48 h and parasite viability in each well was determined
from the residual lactate dehydrogenase activity [23]. Duplicate plates
containing normal erythrocytes (2% haematocrit, 2.0×105 cells/mL), to
determine haemolytic activity of the peptides, were also incubated for 48 h.
After incubation the intact erythrocytes were sedimented in the microtitre plate
wells by centrifugation at 200×g for 3 min in a swing-out rotor. The released
haemoglobin was determined in the supernatants from their absorbance at
405 nm of a 1:8 dilution in water.
2.5. Toxicity assays
HeLa cervical cancer cells and A549 human pulmonary epithelial cells were
cultured in DMEM supplemented with 10% foetal calf serum and penicillin/
streptomycin/fungizone. One day prior to drug pressure, cells were transferred to
96-well plates at a density of 1.5×104 cells/well. Serial dilutions of peptides
were added to each well and, after a 24-h incubation, cell viability was assessed
by adding 20 μL/well resazurin reagent (CellTiter Blue™, Promega, Madison,
WI), incubating for 4 h and measuring absorbance at 585 nm in a microtitre plate
reader.
2.6. Dose–response data analysis
Triplicate or quadruplicate assays were performed for each peptide against
each target cell. All dose–response data was analysed using Graphpad Prism
version 3.01 for Windows (GraphPad Software, San Diego, California USA;
www.graphpad.com). Absorbance values were converted to percentage parasite
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haemolysis or percentage HeLa and A549 cell death (CellTiter Blue™ assay)
and non-linear regression (sigmoidal curve with variable slope) was performed
on the dose–response data. Total growth was determined from control wells with
no peptide added, while total haemolysis was determined by the addition of
200 μM gramicidin S or 250 μg/mL saponin.
The 50% P. falciparum inhibitory concentration (IC50), 50% haemolytic
concentration (HC50) and 50% lethal concentration (LC50) for HeLa and A549
cells were calculated as described by Rautenbach et al. [24]. Apparent selectivity
was calculated by the ratio of HC50/IC50 or LC50/IC50 and defined as selectivity
index.
2.7. Light and fluorescence microscopy
Peptides were added to P. falciparum cultures (2% parasitemia, 2%
haematocrit) at concentrations equal to or above their IC80 values and Giemsa-
stained blood smears prepared at various incubation time points for examination
by light microscopy. Alternatively, aliquots were removed from the cultures,
directly mounted on microscope slides under glass cover slips and viewed by
phase-contrast light microscopy. For fluorescence microscopy analysis, aliquots
removed from peptide-treated cultures were mixed with 4′,6-diamidino-2-
phenylindole (DAPI) and trypan blue in PBS (final concentrations 1 μg/mL and
0.5%, respectively), mounted under coverslips on microscope slides and viewed
by epifluorescence illumination using tetramethyl-rhodamine and ultraviolet
filters. Microscopy assays were done on a Nikon Eclipse E600 fluorescence
microscope fitted with a 100× Apochromat objective and images captured with a
Media Cybernetics CoolSNAP-Pro monochrome cooled CCD camera.
3. Results and discussion
3.1. Peptide preparation
The tyrothricin complex from Sigma contained six major
tyrocidines, with tyrocidine B the most abundant (33.8%) and
tyrocidine C1 the least abundant, as calculated from UPLC peak
areas (Fig. 1, Table 1). Tyrothricin was soluble in aqueous
mixtures of organic solvents (acetonitrile or alcohol), but
concentrations higher than 5 mg/mL resulted in aggregation and
resultant loss of solubility within 30 min. Extraction of
tyrocidines from tyrothricin, with ±60% mass yield, led to
improved solubility in 50% acetonitrile and we were able to
dissolve up to 20 mg/mL for HPLC purification. We suc-Fig. 1. UPLC™-MS chromatogram of tyrothricin. The top value given for each peak is
molecular species of the major component in the eluting peak. The identities of the
Materials and methods, respectively. Compounds in the peaks indicated with asteriskcessfully purified the six major tyrocidines to >90%, as
determined by analytical HPLC. “Impurities” was predomi-
nantly the result of a slight overlap in the collected peak frac-
tions of the major tyrocidines. Purity and identity of the isolated
peptides was confirmed by amino acid analysis (results not
shown), ESMS and UPLC-MS (Table 1).
3.2. Activity of the purified peptides
The activity of the six tyrocidines and the related gramicidin
S was evaluated against the blood stages of P. falciparum using
a 48-h dose–response assay. The timing of the assay allows
viable parasites to complete their full 48-h developmental cycle.
Following erythrocyte invasion, the first stage of the parasite
lasts approximately 16–20 h and is known as the ring stage due
to the ring-like appearance of the parasites by light microscopy
(refer to Fig. 6). The rings gradually enlarge and develop into
trophozoites by 20–24 h after invasion. The trophozoites
continue to expand and fill most of the infected erythrocyte
volume. The schizont stage follows after approximately 36–
40 h, when the nucleus undergoes multiple divisions. At the end
of the schizont stage the plasma membrane invaginates around
each nucleus to give rise to daughter parasites (merozoites) that
are released when the infected erythrocyte ruptures. The
merozoites rapidly invade fresh erythrocytes to re-initiate the
48-h cycle. For any particular peptide, dose–responses were
indistinguishable when the 48 h incubations were initiated with
synchronized cultures containing ring or the more mature
trophozoite stages of the parasite. Gramicidin S was found to be
the least active of all the peptides and only eight times more
inhibitory towards parasite growth (IC50 at 1.3 μM) than lytic
towards uninfected erythrocytes (Table 2). All six the
tyrocidines had IC50 values in the nanomolar range (Figs. 2
and 3; Table 2). The most active tyrocidine preparation,
containing tyrocidine A, had a noteworthy IC50 of 580 pM.
The haemolytic activity of the tyrocidine preparations was
significant and rivaled that of the haemolytic bee-venom
melittin (HC50=2 μM). Although the HC50 values of the tyro-the retention time and the value below is either them/z of [M+H]+ or [M+2H]2+
eluting compounds and chromatographic conditions are detailed in Table 1 and
s were investigated.
Table 1
A summary of the tyrocidines purified for this study
Peptide (Abbr.) Structure Mr exp
(monoisotopic Mr)
Retention time (min):
UPLC; HPLC
Abundance (%)
Tyrocidine A (O-FF) [25] cyclo [VOLFPFFNQY] 1269.68 (1269.7) 9.46; 11.54 23.6
Tyrocidine A1 (K-FF) [26] cyclo [VKLFPFFNQY] 1283.69 (1283.7) 9.29; 10.92 8.5
Tyrocidine B (O-WF) [25] cyclo [VOLFPWFNQY] 1308.74 (1308.7) 8.32; 9.42 33.8
Tyrocidine B1 (K-WF) [26] cyclo [VKLFPWFNQY] 1322.78 (1322.7) 8.15; 8.84 12.8
Tyrocidine C (O-WW) [25] cyclo [VOLFPWWNQY] 1347.76 (1347.7) 7.39; 7.75 16.5
Tyrocidine C1 (K-WW) [26] cyclo [VKLFPWWNQY] 1361.79 (1361.7) 7.27; 7.28 4.8
Gramicidin S [27] cyclo [VOLFPVOLFP] 1140.73 (1140.7) na; 1.41 –
Gramicidin S data are given for comparison. Abbreviations used for peptides indicate the identities of the amino acid residues in the three variable positions.
Conventional one-letter abbreviations are used for amino acids, except that O was used for Orn. The underlined residues in the primary sequences highlight differences
from the tyrocidine A reference sequence. Retention times were determined by UPLC-MS on a C18 column and the experimental Mr by ESMS-TOF (with the
predicted Mr given in brackets). The % abundance is derived from UPLC peak areas.
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8×103 times higher than their corresponding IC50 values, with
tyrocidine A having the highest apparent selectivity index
(Table 2, Figs. 2 and 3). A comparison of Figs. 2A and 3A
clearly shows that the selectivity for the infected erythrocytes
closely followed the activity-sequence trend.
The toxicity of the peptides was evaluated against HeLa and
A549 cells (Table 2 and Fig. 2). The observed LC50 s of the
tyrocidines ranged between 9 and 28 μM. Gramicidin S showed
identical toxicity towards the two eukaryotic cells, but all six the
tyrocidine preparations were slightly less toxic towards the
A549 cells. The LC50 values were between 25 and 4×10
5 times
higher than the corresponding IC50 values, with tyrocidine A
again having the highest apparent selectivity index (Table 2,
Figs. 2 and 3).
3.3. Structure–activity relationships
We opted to use two parameters (apparent hydrophobicity
and side chain surface area) to represent aspects of the overall
chemical and structural character of the peptides. We used
retention time (Rt) on a C18 column as a measure of hydro-
phobicity and, although it is simplistic, we found it a useful
parameter in our structure–activity studies. The two parameters
were correlated with biological activity and selectivity, without
an assumption of mechanism of action or specific target.
An increase in tyrocidine activity against P. falciparum
correlated with an increase in retention on C18-UPLC (andTable 2
Summary of the activity parameters obtained with P. falciparum infected
erythrocytes (IC50), normal erythrocytes (HC50), HeLa cells and A549 cells
(LC50) as target cells
Peptide P. falciparum (nM) RBC (μM) HeLa (μM) A549 (μM)
Tyrocidine A 0.58 4.5 21 14
Tyrocidine A1 4.4 4.1 15 12
Tyrocidin B 61 2.6 17 12
Tyrocidin B1 310 8.6 28 24
Tyrocidin C 290 3.2 13 12
Tyrocidin C1 460 5.4 16 12
Gramicidin S 1300 11 7.4 7.5
All values are given to only two significant digits. The standard error of the
mean is <5% for all the IC50 and HC50 values, and <15% for all the LC50 values.analytical C18-HPLC), which is related to apparent hydro-
phobicity (Fig. 2). This suggests that overall hydrophobicity is a
major determinant of the anti-parasitic activity of the peptides.
The composition of the aromatic dipeptide unit, containing Phe
and/or Trp, is the main distinguishing feature of the individual
tyrocidine peptides (Table 1). Besides conferring differences in
hydrophobicity, Phe and Trp also differ greatly in surface area
[29,30]. We found an inverse linear correlation (R2 =0.91)
between the Σ(side chain surface area) of the tyrocidines and
antiplasmodial activity (Fig. 2B). This suggests that steric
factors may influence antiplasmodial activity in addition to
hydrophobicity. Interestingly, we also found a good linear
inverse correlation (R2 =0.95) between retention time and side
chain surface area, which suggests that the interaction of the
larger Trp and Lys side chains with the C18-acyl chains is
weaker.
Although a number of studies on antimicrobial peptides
proposed that hydrophobicity is directly related to haemolytic
activity [28,29], we found no clear relationship between hae-
molytic activity or mammalian cell toxicity and retention on
the hydrophobic C18 columns (Table 2, Fig. 2A). Conse-
quently, selectivity for the infected erythrocyte or parasite
mirrored the antiplasmodial trends: selectivity depends on
the apparent hydrophobicity of the isolated tyrocidine and
the selectivity index increases with an increase in retention
on the C18 matrix (Fig. 3A). In addition, there is a good
exponential correlation (R2 =0.999) between the Σ(side
chain surface area) and selectivity for infected erythrocytes
(Fig. 3B).
Further correlations were found between activity and the
primary structure of the major tyrocidine in each preparation.
The presence of Lys instead of Orn in the conserved VOLFP
pentapeptide results in a marked decrease in antiplasmodial
activity, which further correlates with a decrease in haemolytic
activity and toxicity (compare K-FF, K-WF and K-WW with
O-FF, O-WF and O-WW respectively in Table 2 and Fig. 3A).
This suggests that lytic activity may contribute to tyrocidine
action which may in turn depend on the chemical character of
the Orn/Lys side chains in the cyclic peptide structure. The side
chains of Lys and Orn differ due to the ε- and γ-amino groups
(pKa=10.54 vs. pKa=10.76 respectively) [31] and in terms of
hydropathy (−9.9 and −9.0 respectively, according to Tossi's
Fig. 2. Relationship between peptide activity and peptide hydrophobicity (A) or
∑ (side chain volume) (B) (A) Peptide activity against mammalian cells (LC50),
erythrocytes (HC50) and P. falciparum parasites (IC50) vs. apparent hydro-
phobicity, as determined by retention on a C18-UPLC column. (B) IC50 vs.
peptide∑ (side chain volume). The linear fit has a R2=0.91. Side chain surface
areas are from [29], as calculated from Connolly surfaces [30]. Refer to Table 1
for an explanation of abbreviations and peptide identities.
Fig. 3. Relationship between the selectivity index and (A) apparent
hydrophobicity, as determined by retention on a C18 column, and (B) ∑ (side
chain volume), the insert shows the exponential fit to the data, R2=0.999. The
selectivity index was calculated from IC50/HC50 and IC50/LC50 ratios. Side
chain surface areas are from [29], as calculated from Connolly surfaces [30].
Refer to Table 1 for abbreviations and peptide identities.
1492 M. Rautenbach et al. / Biochimica et Biophysica Acta 1768 (2007) 1488–1497new hydropathy consensus scale) [32]. These differences can
thus influence activity in a membrane environment, or binding
to a different target.
Our data further indicate that the first Phe in the aromatic
dipeptide unit is an important determinant of antiplasmodial
activity and specificity. The presence of Trp instead of Phe in
the first position of the FFNQYpentapeptide moiety produced a
pronounced decrease in antiplasmodial activity (70 and 105
times for the Lys and Orn analogues respectively), but has little
effect on haemolytic activity and cytotoxicity (Fig. 3, Table 2).
Trp instead of Phe in the second position, however, does not
markedly influence activity (1.5 and 4.8 times for the Lys and
Orn analogues respectively).
Gramicidin S eluted much earlier from the C18 column than
any of the tyrocidines and was much less active than the
tyrocidines (Tables 1 and 2), however, it retained a comparablehaemolytic activity and showed a higher toxicity. Gramicidin S
lacks the FFNQY pentapeptide unit and has two VOLFP
pentapeptide moieties, indicating the importance of the
FFNQY sequence in antiplasmodial activity. It is possible
that the cytolytic activity depends on the VOLFP sequence,
while the FFNQY sequence might promote a non-lytic trans-
location which in turn depends on the binding mode, as ex-
plained below.
In the light that binding to the target cell membrane is
possibly the first committed step in the tyrocidines mechanism
of action, the above structure–activity correlations may also be
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to the target membrane. Aromatic amino acid residues tend to
prefer the membrane interface between head-groups and lipid
layer—Trp has a shallow insertion and is inclined to form
hydrogen bonds via its NH-group with fatty-acyl carbonyl
groups [33], while Phe inserts deeper into the bilayer [34,35].
There are also differences between the binding of Orn and Lys,
with the longer Lys side-chain binding stronger due to a
“snorkel effect” (the longer butylene chain interacts with the
acyl chains, while the amino group remains associated with the
head groups in the aqueous phase) [36]. During binding, Phe
and Lys would cause deeper insertion of the cyclic peptide into
the membrane, while Trp and Orn would lead to shallowerFig. 4. Fluorescence microscopy of infected erythrocytes incubated with trypan
fluorescence in red and DAPI fluorescence in blue, while right hand panels are the cor
fluorescence clearly delineates the infected erythrocyte membrane (arrowhead, top pa
parasite-derived structures in the infected erythrocyte cytoplasm (arrow, bottom pan
Cultures treated with 8 μM gramicidin S for 30 min. Parasites are surrounded by a lyse
panel). In addition, trypan blue has penetrated the parasite and accumulates intense
(arrows, both panels). (C) Control cultures after 6 h. Top panel shows two adjacen
schizont-stage parasite containing multiple nuclei, as indicated by the DAPI staining.
treated with 30 nM tyrocidine A for 6 h. Top panel shows an erythrocyte infected wi
two nuclei.binding. It is therefore possible that two phenylalanines, rather
than one (for example the first Phe), are necessary in the
aromatic dipeptide unit to ensure deep penetration into the
membrane during binding. On the other hand, the tighter
binding of Lys may be detrimental to the tyrocidine
mechanism of action, for example, by causing the peptide to
be trapped in an unfavourable conformation. This differential
binding may also explain the direct linear relationship
(R2 =0.91) we observed between side chain surface area and
anti-plasmodium activity. Alternatively, if membrane binding
is not part of the tyrocidine mechanism of action, the FFNQY
moiety may be specific for a separate sensitive target in the
parasite.blue and DAPI. Left hand panels are fluorescence images, with trypan blue
responding phase-contrast images. (A) Control cultures after 30 min. Trypan blue
nel) and parasite plasma membrane (arrow, top panel) and is also associated with
el). The parasite nucleus (chromatin) is shown by the DAPI fluorescence. (B)
d erythrocyte ghost membrane, staining lightly with trypan blue (arrowhead, top
ly around the haemozoin crystal, which is found in the parasite food vacuole
t parasite-infected erythrocytes. The erythrocyte on the left is infected with a
Bottom panel shows an erythrocyte infected with two trophozoites. (D) Cultures
th two trophozoites. Bottom panel, an erythrocyte with a trophozoite containing
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P. falciparum cultures
We used light and fluorescence microscopy to gauge the
effect of these membrane active cyclic peptides on P. falciparum
infected erythrocytes. In order to evaluate changes in parasite
permeability, the cells were treated with the peptides below their
respective haemolytic concentrations and visualised by fluores-
cence microscopy in the presence of an impermeant marker for
cell leakage (trypan blue). We previously described this type of
experiment on erythrocytes infected with mature stage
P. falciparum and treated with lytic polyene antibiotics [12].
The plasma membrane of trophozoite-infected erythrocytes
is more permeable to low molecular weight solutes than
uninfected or ring-infected erythrocytes [37]. Consequently, in
control trophozoite cultures, trypan blue was found not only
associated with the erythrocyte plasma membrane (Fig. 4A top
panel, arrowhead), but also inside the infected erythrocyte
cytoplasm where it bound to parasite-derived structures (Fig. 4A
bottom panel, arrow) and the plasma membrane of the parasite
(Fig. 4A top panel, arrow), but with no staining inside the
parasite itself. Uninfected erythrocytes appeared intact and
impermeable to trypan, as expected. By contrast, in gramicidin
S-treated trophozoite cultures, the parasites were surrounded by
an erythrocyte ghost membrane bound to trypan blue (Fig. 4B,
arrowhead), indicating lysis of the infected erythrocyte mem-
brane. Trypan blue fluorescence was also clearly visible inside
the trophozoite, notably surrounding the hemozoin crystal which
denotes the position of the parasite digestive food vacuole (Fig.
4B, arrows), which suggests lysis of the parasite plasmaFig. 5. Phase-contrast light microscopy of trophozoite-infected erythrocytes incubated
erythrocyte ghost; (C) Released trophozoite free of surrounding erythrocyte membra
parasites in erythrocyte ghosts and the eventual release of the trophozoites during amembrane as well. The latter conclusion is supported by the
results obtained with the membrane permeable DNA stain and
nuclear marker, DAPI, which was included to evaluate changes
in the chromatin packing (gramicidin S and the tyrocidines have
been shown to interact with DNA [38–41]). Gramicidin S had a
pronounced influence on the chromatin, as we observed diffuse
DAPI staining spilling into the erythrocyte ghost after
gramicidin S challenge (compare Figs. 4A and B). The presence
of parasite DNA in the erythrocyte ghost confirms lysis of
parasite nuclear and plasma membranes by the peptide.
Gramicidin S-treated ring-infected erythrocytes and uninfected
erythrocytes retained their native impermeability to trypan blue,
however (results not shown). More importantly, in contrast to
gramicidin S, the tyrocidines did not significantly affect DAPI
staining of the parasite nuclei or the trypan blue fluorescence
(compare Figs. 4C and D). This suggests that the parasites and
infected erythrocytes maintain their integrity in the face of
tyrocidine challenge and that the latter peptides act by a
mechanism of action different from the rapid, overt lysis of
trophozoites and trophozoite-infected erythrocytes caused by
gramicidin S.
Real-time visualisation of the effect of the peptides was
accomplished by monitoring trophozoite stage cultures chal-
lenged with peptides at sub-haemolytic concentrations by phase-
contrast light microscopy. Treatment with 8 μM gramicidin S
caused the formation >20% trophozoites in ghosts in less than a
min and almost 70% after 8 min (Fig. 5). After 40 min only 1%
infected erythrocytes survived and >30% free trophozoites were
found. We also observed that gramicidin S rapidly lysed
erythrocyte-free trophozoites isolated from infected cultures bywith gramicidin S. (A) Trophozoite in an intact erythrocyte; (B) Trophozoite in
nes. The bar graph shows the progressive lysis of infected erythrocytes to yield
40 min incubation with 8 μM gramicidin S.
Fig. 6. Giemsa-stained blood smears from P. falciparum cultures treated with
tyrocidine A. 30 nM tyrocidine Awas added to synchronized cultures containing
either ring or trophozoite stage parasites (ring and trophozoite starter cultures,
respectively). At 0 h, trophozoite starter cultures contained mature trophozoites
(thick arrow) in normal erythrocytes (arrowhead), as did control and tyrocidine
A-treated cultures after 8 h. After 21 h, control cultures contained schizonts
(thick arrow) and abundant rings (thin arrow). The bar graph depicts the
distribution of parasite stages in the cultures after 21 h (including those obtained
with cultures treated with 800 nM tyrocidine C1).
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trypan blue and DAPI fluorescence experiments obtained with
gramicidin S. In addition, they confirm the ability of some
membrane active compounds to selectively lyse parasites and
erythrocytes infected with mature parasites, as found for polyene
antibiotics in our previous study [12] and highlight the infected
erythrocyte membrane as a target for the development of
potential antimalarial compounds. By contrast, as with the
fluorescence microscopy experiments, the tyrocidines failed to
produce visible changes to infected erythrocytes during incuba-
tions of up to 1 h.
Due to this lack of observable effects on infected erythrocytes
during incubation with the tyrocidines, visualisation of
tyrocidine action over a longer period was done by microscopic
evaluation of Giemsa-stained smears. Smears of parasite
cultures were prepared at various time-points following
addition of sub-haemolytic tyrocidine A or C concentrations.
After 6 h, there were no discernable morphological changes
compared to controls (Fig. 6). However, after 21 h of incubation
with the tyrocidines, a pronounced effect on parasite develop-
ment was observed and progression of the life-cycle was
inhibited or retarded. Addition of the tyrocidines to ring stage
cultures (Fig. 6, see “ring starter cultures”) did not influence
development into trophozoites or parasite numbers (expressed
as % parasitemia in the bar graph), but the trophozoites were
much smaller and more immature in appearance than those in
the control cultures, suggesting a delay in development. In
experiments initiated with trophozoite cultures (Fig. 6, see
“trophozoite starter cultures”), control parasites had progressed
normally, traversed the schizont stage during which cell
division occurs and re-invaded erythrocytes to form rings, the
predominant parasite stage in the culture after 21 h (Fig. 6, bar
graph). By contrast, tyrocidine-treated cultures contained
normal-looking schizonts and late trophozoites (Fig. 6), but
comparatively few rings (Fig. 6, refer to bar graph, compare
ring % parasitemia of control and treated cultures), again
suggesting an inhibition of parasite maturation and progression
through the life-cycle. This visual evaluation over 21 h suggests
that the tyrocidines may have static activity towards the
parasites. However, our dose response data over 48 h showed
that virtually none on the parasites survived at the highest non-
haemolytic concentrations we tested, indicating a “slow”
cytocidal activity. In separate experiments, where tyrocidines
were added to schizont-stage cultures for 6 h, invasion and ring
formation per se was found to be insensitive to tyrocidines and
was not responsible for the absence of rings in the 21 h
experiments described above (results not shown).
4. Conclusions
We were able to isolate six tyrocidines, with nanomolar
activity towards P. falciparum, from a commercial tyrothricin
complex. An increase in apparent hydrophobicity and decrease
in side chain surface area of the major tyrocidine in each
preparation correlated remarkably well with an increase the P.
falciparum selective activity. These correlations may be the
consequence of differences in the binding of the peptides to the
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tyrocidines mechanism of action, which in turn depends on the
presence of Phe, Trp, Lys and Orn in key positions of the
sequence. For example, the most active and hydrophobic
peptide, tyrocidine A, has Orn and Phe–Phe in its primary
structure, while Lys and Trp–Trp is found in the least active and
most polar peptide, Tyrocidine C1 (cyclo-VKLFPWWNQY).
The activity of the related, but more polar and smaller,
gramicidin S differed significantly from the tyrocidines.
Gramicidin S has a lower activity and specificity and its
rapid lethal action is due to lysis of trophozoite-infected
erythrocytes, as found previously for amphotericin B and
related haemolytic polyene macrolides [12,42]. However,
unlike amphotericin B, gramicidin S also causes the
disruption of parasite membranes and chromatin. The
antiplasmodial activity of the related tyrocidines does not
depend on overt haemolysis, but an inhibition of parasite
development. Current results do not allow firm conclusions to
be drawn regarding the precise mode of action of the
tyrocidines. The erythrocyte membrane is the first target
encountered by these membrane-active peptides; they are
haemolytic at micromolar concentrations and related structu-
rally to gramicidin S, which selectively destroys infected
erythrocyte membranes. Conceivably, the tyrocidines may
disturb the permeability of infected erythrocyte membranes
and affect the ability of the parasite to regulate small
molecule homeostasis in its host cell, resulting in a gradual
inhibition of parasite development. Alternatively, a tyrocidine
sensitive molecular target is present in the infected cell or
parasite itself, causing a delay in maturation. The tyrocidine
activity towards this putative target is dependent on Phe in the
aromatic dipeptide unit and Orn in the conserved pentapeptide
moiety. Ongoing analysis of additional tyrocidines from the
tyrothricin mixture and synthetic variants is important in
estimating the optimal/minimal structural determinants of
antiplasmodial activity and selectivity, which in turn will
guide the design and synthesis of peptide derivatives and
mimics for therapeutic evaluation. Specifically, Phe–Trp
analogues will be included in future studies to clarify the
role of the Phe in the first position of the aromatic dipeptide
unit.
Although the haemolytic activity of most the tyrocidines in
this study may be a concern, a number of tyrocidines and
tyrocidine-like peptides remain to be evaluated for antiplasmo-
dial activity. Due to the pronounced selective activity of
tyrocidine A, this peptide and other tyrocidines with similar
hydrophobic properties may be promising candidates for
deriving lead compounds specific for P. falciparum-infected
erythrocytes.
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